About us
A community obsessed with pragmatic science and powered by empathy.
About us
A community obsessed with pragmatic science and powered by empathy.
Why We Started
The Story Behind Our Mission
A strong desire for people living with chronic conditions to have fewer daily burdens. A belief in quality of life is just as important (if not more) than how long we live.
A strong desire for people living with chronic conditions to have fewer daily burdens. A belief in quality of life is just as important (if not more) than how long we live.
Hear it from Our Founder
"When I was diagnosed with Arthritis, finding an effective anti-inflammatory supplement was simply impossible. It was just trial and error with no clear guidance on what worked. This personal experience revealed a critical gap: while the supplement industry focuses on general wellness, people with serious chronic conditions need science backed solutions that are easy to find."
This also triggered my involvement in translational science to reduce patients' burden.
Bassam Nasreddine Karout.
Founder of Milltons
"When I was diagnosed with Arthritis, finding an effective anti-inflammatory supplement was simply impossible. It was just trial and error with no clear guidance on what worked. This personal experience revealed a critical gap: while the supplement industry focuses on general wellness, people with serious chronic conditions need science backed solutions that are easy to find."
This also triggered my involvement in translational science to reduce patients' burden.
Bassam Nasreddine Karout.
Founder of Milltons
"When I was diagnosed with Arthritis, finding an effective anti-inflammatory supplement was simply impossible. It was just trial and error with no clear guidance on what worked. This personal experience revealed a critical gap: while the supplement industry focuses on general wellness, people with serious chronic conditions need science backed solutions that are easy to find."
This also triggered my involvement in translational science to reduce patients' burden.
Bassam Nasreddine Karout.
Founder of Milltons
"When I was diagnosed with Arthritis, finding an effective anti-inflammatory supplement was simply impossible. It was just trial and error with no clear guidance on what worked. This personal experience revealed a critical gap: while the supplement industry focuses on general wellness, people with serious chronic conditions need science backed solutions that are easy to find."
This also triggered my involvement in translational science to reduce patients' burden.
Bassam Nasreddine Karout.
Founder of Milltons
"When I was diagnosed with Arthritis, finding an effective anti-inflammatory supplement was simply impossible. It was just trial and error with no clear guidance on what worked. This personal experience revealed a critical gap: while the supplement industry focuses on general wellness, people with serious chronic conditions need science backed solutions that are easy to find."
This also triggered my involvement in translational science to reduce patients' burden.
Bassam Nasreddine Karout.
Founder of Milltons
"When I was diagnosed with Arthritis, finding an effective anti-inflammatory supplement was simply impossible. It was just trial and error with no clear guidance on what worked. This personal experience revealed a critical gap: while the supplement industry focuses on general wellness, people with serious chronic conditions need science backed solutions that are easy to find."
This also triggered my involvement in translational science to reduce patients' burden.
Bassam Nasreddine Karout.
Founder of Milltons
"When I was diagnosed with Arthritis, finding an effective anti-inflammatory supplement was simply impossible. It was just trial and error with no clear guidance on what worked. This personal experience revealed a critical gap: while the supplement industry focuses on general wellness, people with serious chronic conditions need science backed solutions that are easy to find."
This also triggered my involvement in translational science to reduce patients' burden.
Bassam Nasreddine Karout.
Founder of Milltons
"When I was diagnosed with Arthritis, finding an effective anti-inflammatory supplement was simply impossible. It was just trial and error with no clear guidance on what worked. This personal experience revealed a critical gap: while the supplement industry focuses on general wellness, people with serious chronic conditions need science backed solutions that are easy to find."
This also triggered my involvement in translational science to reduce patients' burden.
Bassam Nasreddine Karout.
Founder of Milltons
"When I was diagnosed with Arthritis, finding an effective anti-inflammatory supplement was simply impossible. It was just trial and error with no clear guidance on what worked. This personal experience revealed a critical gap: while the supplement industry focuses on general wellness, people with serious chronic conditions need science backed solutions that are easy to find."
This also triggered my involvement in translational science to reduce patients' burden.
Bassam Nasreddine Karout.
Founder of Milltons
"When I was diagnosed with Arthritis, finding an effective anti-inflammatory supplement was simply impossible. It was just trial and error with no clear guidance on what worked. This personal experience revealed a critical gap: while the supplement industry focuses on general wellness, people with serious chronic conditions need science backed solutions that are easy to find."
This also triggered my involvement in translational science to reduce patients' burden.
Bassam Nasreddine Karout.
Founder of Milltons
Who are we
A community obsessed with pragmatic science and powered by empathy. Our last 15 years of work have brought together persons from different walks of life with two things in common:
A community obsessed with pragmatic science and powered by empathy. Our last 15 years of work have brought together persons from different walks of life with two things in common:
Empathy
A strong desire for people living with chronic conditions to have fewer daily burdens. A belief that quality of life is just as important (if not more) than how long we live.
Empathy
A strong desire for people living with chronic conditions to have fewer daily burdens. A belief that quality of life is just as important (if not more) than how long we live.
Empathy
A strong desire for people living with chronic conditions to have fewer daily burdens. A belief that quality of life is just as important (if not more) than how long we live.
Revolution
An unwavering urge to change the status quo to better treatments, better diagnostics and a different better approach to chronic complications.
Revolution
An unwavering urge to change the status quo to better treatments, better diagnostics and a different better approach to chronic complications.
Revolution
An unwavering urge to change the status quo to better treatments, better diagnostics and a different better approach to chronic complications.
A Community Obsessed with Pragmatic Science
We've revolutionised supplement filtering by staying completely independent. No patents on our breakthroughs, no external investors to please. Just 15 years of unwavering commitment to reducing unnecessary suffering for people with chronic conditions.
A Community Obsessed with Pragmatic Science
We've revolutionised supplement filtering by staying completely independent. No patents on our breakthroughs, no external investors to please. Just 15 years of unwavering commitment to reducing unnecessary suffering for people with chronic conditions.
A Community Obsessed with Pragmatic Science
We've revolutionised supplement filtering by staying completely independent. No patents on our breakthroughs, no external investors to please. Just 15 years of unwavering commitment to reducing unnecessary suffering for people with chronic conditions.
A patient-first network for a changing world
Our network provides physicians of all specialties and at all stages with the essential tools to modernise patient operations and help their treatment thrive.
Our network provides physicians of all specialties and at all stages with the essential tools to modernise patient operations and help their treatment thrive.
Barcelona since 2009
Barcelona since 2009
Barcelona since 2009
Yesfal- in Barcelona since 2009- trading pharmaceuticals and food supplements withclinical studies to medical companies around the world.
Yesfal- in Barcelona since 2009- trading pharmaceuticals and food supplements withclinical studies to medical companies around the world.
Yesfal- in Barcelona since 2009- trading pharmaceuticals and food supplements withclinical studies to medical companies around the world.
Cambridge UK since 2015
Cambridge UK since 2015
Cambridge UK since 2015
Milltons- in Cambridge UK since 2015, running pragmatic research in Diabetes and Cystic Fibrosis in Sweden, Denmark, Greece and some non-European countries. Some of the researchers involved are considered the reference in their industry, and all of them are still active physicians- they still meet patients and understand their “unnecessary” daily suffering.
Milltons- in Cambridge UK since 2015, running pragmatic research in Diabetes and Cystic Fibrosis in Sweden, Denmark, Greece and some non-European countries. Some of the researchers involved are considered the reference in their industry, and all of them are still active physicians- they still meet patients and understand their “unnecessary” daily suffering.
Milltons- in Cambridge UK since 2015, running pragmatic research in Diabetes and Cystic Fibrosis in Sweden, Denmark, Greece and some non-European countries. Some of the researchers involved are considered the reference in their industry, and all of them are still active physicians- they still meet patients and understand their “unnecessary” daily suffering.
Stockholm since 2020
Stockholm since 2020
Stockholm since 2020
DICODI - Swedish research collaboration since 2020, conducting groundbreaking studies on gastrointestinal complications in diabetes through partnerships between Uppsala University, Lund University, and Aalborg University. The research involves active physicians and medical professionals who understand the daily challenges patients face with undiagnosed complications.
DICODI - Swedish research collaboration since 2020, conducting groundbreaking studies on gastrointestinal complications in diabetes through partnerships between Uppsala University, Lund University, and Aalborg University. The research involves active physicians and medical professionals who understand the daily challenges patients face with undiagnosed complications.
DICODI - Swedish research collaboration since 2020, conducting groundbreaking studies on gastrointestinal complications in diabetes through partnerships between Uppsala University, Lund University, and Aalborg University. The research involves active physicians and medical professionals who understand the daily challenges patients face with undiagnosed complications.
Evidence-Based Platform
Join our community of patients accessing clinically validated supplements and patient centric research in Europe.
Evidence-Based Platform
Join our community of patients accessing clinically validated supplements and patient centric research in Europe.
Built by Patients, For Patients
Join our community of patients accessing clinically validated supplements and patient centric research in Europe.
Built by Patients, For Patients